These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 26437156)
21. Subtrochanteric fracture in a patient receiving zoledronic acid therapy for metastatic breast cancer. Kishimoto Y; Iwase T; Koyama A; Masui T; Yoshida G; Matsuo H; Ishiguro N Nagoya J Med Sci; 2011 Aug; 73(3-4):211-5. PubMed ID: 21928703 [TBL] [Abstract][Full Text] [Related]
22. Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer. Moore MM; Beith JM Med J Aust; 2008 Mar; 188(6):370-1. PubMed ID: 18341464 [No Abstract] [Full Text] [Related]
23. [A Case of Fanconi Syndrome Induced by Zoledronic Acid in a Metastatic Colorectal Cancer Patient]. Okagawa Y; Sato Y; Onuma H; Osuga T; Hayashi T; Sato T; Miyanishi K; Kobune M; Takimoto R; Kato J Gan To Kagaku Ryoho; 2015 Jul; 42(7):867-70. PubMed ID: 26197752 [TBL] [Abstract][Full Text] [Related]
24. Synchronous antiresorptive osteonecrosis of the jaws and breast cancer metastasis. Flores IL; dos Santos-Silva AR; Della Coletta R; Vargas PA; Lopes MA Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):e264-8. PubMed ID: 24528798 [TBL] [Abstract][Full Text] [Related]
25. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo. Ottewell PD; Deux B; Mönkkönen H; Cross S; Coleman RE; Clezardin P; Holen I Clin Cancer Res; 2008 Jul; 14(14):4658-66. PubMed ID: 18628481 [TBL] [Abstract][Full Text] [Related]
26. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy. Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071 [TBL] [Abstract][Full Text] [Related]
27. A case of femoral diaphyseal fracture after long-term treatment with zoledronic acid. Ishizuna K; Ota D; Fukuuchi A; Teraoka M; Fujii A; Mori M; Nishi T Breast Cancer; 2015 Jan; 22(1):90-4. PubMed ID: 22009549 [TBL] [Abstract][Full Text] [Related]
29. Zoledronic acid treatment at home: safety data from an observational prospective trial. Tassinari D; Poggi B; Nicoletti S; Fantini M; Tamburini E; Possenti C; Sartori S J Palliat Med; 2007 Apr; 10(2):352-8. PubMed ID: 17472506 [TBL] [Abstract][Full Text] [Related]
30. Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy. Megna M; Cinelli E; Napolitano M; Fabbrocini G; Patruno C Contact Dermatitis; 2019 Dec; 81(6):451-454. PubMed ID: 31328275 [No Abstract] [Full Text] [Related]
31. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Rosen LS; Gordon D; Kaminski M; Howell A; Belch A; Mackey J; Apffelstaedt J; Hussein M; Coleman RE; Reitsma DJ; Seaman JJ; Chen BL; Ambros Y Cancer J; 2001; 7(5):377-87. PubMed ID: 11693896 [TBL] [Abstract][Full Text] [Related]
32. A case of acquired Fanconi syndrome induced by zoledronic acid. Yoshinami T; Yagi T; Sakai D; Sugimoto N; Imamura F Intern Med; 2011; 50(9):1075-9. PubMed ID: 21532237 [TBL] [Abstract][Full Text] [Related]
33. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) induced by amoxicillin-clavulanate. Dogru M; Ozmen S; Ginis T; Duman H; Bostanci I Pediatr Dermatol; 2012; 29(6):770-1. PubMed ID: 22044408 [TBL] [Abstract][Full Text] [Related]
34. Cabrera Hernandez V; Gonzalez Afonso M; Callero Viera A; Martin-Fernandez Martin L BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31377719 [TBL] [Abstract][Full Text] [Related]
36. [Efficacy of zoledronate in treating persisting isolated tumor cells in bone marrow in patients with breast cancer. A phase II pilot study]. Rack B; Schindlbeck C; Strobl B; Sommer H; Friese K; Janni W Dtsch Med Wochenschr; 2008 Feb; 133(7):285-9. PubMed ID: 18253918 [TBL] [Abstract][Full Text] [Related]
38. Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis. John Camm A Clin Ther; 2010 Mar; 32(3):426-36. PubMed ID: 20399982 [TBL] [Abstract][Full Text] [Related]
39. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil. Powers R; Gordon R; Roberts K; Kovach R Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435 [TBL] [Abstract][Full Text] [Related]
40. A new proposal for a clinical-oriented subclassification of baboon syndrome and a review of baboon syndrome. Miyahara A; Kawashima H; Okubo Y; Hoshika A Asian Pac J Allergy Immunol; 2011 Jun; 29(2):150-60. PubMed ID: 21980830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]